Citadel Advisors’s Chemours CC Stock Holding History

Citadel Advisors’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.68M	Buy	439,400 +97,900	+29%	+$1.7M	﹤0.01%	3306
2025 Q4	$4.03M	Buy	341,500 +55,900	+20%	+$718K	﹤0.01%	4641
2025 Q3	$4.52M	Buy	285,600 +100,900	+55%	+$1.46M	﹤0.01%	4541
2025 Q2	$2.11M	Buy	184,700 +70,100	+61%	+$790K	﹤0.01%	5604
2025 Q1	$1.55M	Sell	114,600 -97,600	-46%	-$1.62M	﹤0.01%	6025
2024 Q4	$3.59M	Sell	212,200 -3,700	-2%	-$72K	﹤0.01%	4526
2024 Q3	$4.39M	Sell	215,900 -130,700	-38%	-$2.67M	﹤0.01%	4162
2024 Q2	$7.82M	Sell	346,600 -163,900	-32%	-$4.29M	﹤0.01%	3103
2024 Q1	$13.4M	Buy	510,500 +272,600	+115%	+$7.77M	﹤0.01%	2544
2023 Q4	$7.5M	Sell	237,900 -59,900	-20%	-$1.63M	﹤0.01%	3218
2023 Q3	$8.35M	Sell	297,800 -15,100	-5%	-$518K	﹤0.01%	2917
2023 Q2	$11.5M	Buy	312,900 +159,900	+105%	+$4.88M	﹤0.01%	2485
2023 Q1	$4.58M	Sell	153,000 -85,700	-36%	-$2.82M	﹤0.01%	3963
2022 Q4	$7.31M	Sell	238,700 -39,600	-14%	-$1.19M	﹤0.01%	3262
2022 Q3	$6.86M	Buy	278,300 +52,600	+23%	+$1.74M	﹤0.01%	3352
2022 Q2	$7.23M	Sell	225,700 -22,100	-9%	-$813K	﹤0.01%	3150
2022 Q1	$7.8M	Buy	247,800 +111,400	+82%	+$3.48M	﹤0.01%	3369
2021 Q4	$4.58M	Sell	136,400 -62,700	-31%	-$1.95M	﹤0.01%	4474
2021 Q3	$5.79M	Sell	199,100 -9,800	-5%	-$317K	﹤0.01%	4030
2021 Q2	$7.27M	Sell	208,900 -56,900	-21%	-$1.88M	﹤0.01%	3676
2021 Q1	$7.42M	Buy	265,800 +98,800	+59%	+$2.63M	﹤0.01%	3469
2020 Q4	$4.14M	Sell	167,000 -32,500	-16%	-$773K	﹤0.01%	3991
2020 Q3	$4.17M	Sell	199,500 -45,900	-19%	-$886K	﹤0.01%	3421
2020 Q2	$3.77M	Sell	245,400 -107,700	-31%	-$1.36M	﹤0.01%	3490
2020 Q1	$3.13M	Buy	353,100 +72,500	+26%	+$1.05M	﹤0.01%	3395
2019 Q4	$5.08M	Buy	280,600 +106,900	+62%	+$1.78M	﹤0.01%	3059
2019 Q3	$2.6M	Buy	173,700 +9,000	+5%	+$146K	﹤0.01%	4080
2019 Q2	$3.95M	Buy	164,700 +51,900	+46%	+$1.53M	﹤0.01%	3444
2019 Q1	$4.19M	Buy	112,800 +4,700	+4%	+$171K	﹤0.01%	3250
2018 Q4	$3.05M	Buy	108,100 +29,900	+38%	+$946K	﹤0.01%	3490
2018 Q3	$3.08M	Sell	78,200 -18,100	-19%	-$792K	﹤0.01%	3692
2018 Q2	$4.27M	Buy	96,300 +2,400	+3%	+$119K	﹤0.01%	2974
2018 Q1	$4.57M	Sell	93,900 -21,800	-19%	-$1.09M	﹤0.01%	2562
2017 Q4	$5.79M	Sell	115,700 -46,100	-28%	-$2.41M	﹤0.01%	2312
2017 Q3	$8.19M	Buy	161,800 +31,600	+24%	+$1.49M	0.01%	1790
2017 Q2	$4.94M	Buy	130,200 +20,600	+19%	+$813K	﹤0.01%	2146
2017 Q1	$4.22M	Sell	109,600 -75,700	-41%	-$2.28M	﹤0.01%	2210
2016 Q4	$4.09M	Buy	185,300 +112,900	+156%	+$2.32M	﹤0.01%	2193
2016 Q3	$1.16M	Buy	72,400 +45,000	+164%	+$514K	﹤0.01%	3642
2016 Q2	$226K	Buy	27,400 +14,200	+108%	+$127K	﹤0.01%	5649
2016 Q1	$92K	Sell	13,200 -3,100	-19%	-$15.6K	﹤0.01%	6062
2015 Q4	$87K	Buy	16,300 +6,400	+65%	+$40.9K	﹤0.01%	6837
2015 Q3	$64K	Buy	+9,900	New	+$104K	﹤0.01%	7385

Other funds holding CC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

WHCM

Wolf Hill Capital Management Greenwich, Connecticut $1.03B AUM 80.44% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citadel Advisors's CC Position: Q1 2026 in Review

Citadel Advisors increased its Chemours (CC) stake by 161% in Q1 2026, buying an estimated $3.06M and bringing the position to 285,007 shares worth $6.28M. The position accounts for ﹤0.01% of the portfolio, ranked #3973.

Citadel Advisors first reported a position in CC in Q3 2015 and has held it in 40 quarters since. The position peaked at $67.2M in Q2 2023. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

Citadel Advisors held 285,007 shares of Chemours worth $6.28M as of Q1 2026.
Citadel Advisors bought 175,852 Chemours shares in Q1 2026, an estimated $3.06M.
Chemours made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #3973 holding.
Citadel Advisors first reported a position in Chemours in Q3 2015 and has held it in 40 quarters since.
Citadel Advisors's Chemours position peaked at $67.2M in Q2 2023.
448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.